Report overview
This report aims to provide a comprehensive presentation of the global market for Pharmerging, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmerging. This report contains market size and forecasts of Pharmerging in global, including the following market information:
Global Pharmerging Market Revenue, 2019-2024, 2024-2029, ($ millions)
Global top five companies in 2023 (%)
The global Pharmerging market was valued at US$ 934 million in 2023 and is projected to reach US$ 1630.9 million by 2029, at a CAGR of 8.3% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Tier 1 Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Pharmerging include Pfizer, Sanofi, GlaxoSmithKline, AstraZeneca, Novartis, Johnson & Johnson, F. Hoffmann-La Roche, Eli Lilly and Boehringer Ingelheim, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pharmerging companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pharmerging Market, by Type, 2019-2024, 2024-2029 ($ millions)
Global Pharmerging Market Segment Percentages, by Type, 2023 (%)
Tier 1
Tier 2
Tier 3
Global Pharmerging Market, by Application, 2019-2024, 2024-2029 ($ millions)
Global Pharmerging Market Segment Percentages, by Application, 2023 (%)
Lung Cancer
Breast Cancer
Chronic Myeloid Leukemia
Lymphomas
Other
Global Pharmerging Market, By Region and Country, 2019-2024, 2024-2029 ($ Millions)
Global Pharmerging Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pharmerging revenues in global market, 2019-2024 (estimated), ($ millions)
Key companies Pharmerging revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Sanofi
GlaxoSmithKline
AstraZeneca
Novartis
Johnson & Johnson
F. Hoffmann-La Roche
Eli Lilly
Boehringer Ingelheim
Novo Nordisk
AbbVie
Sun Pharmaceutical
Teva Pharmaceutical Industries
Mitsubishi Tanabe Pharma
Bristol-Myers Squibb
Kyowa Hakko Kirin
CSL Behring
Takeda
Amgen
Bayer
Biogen
Eisai
Daiichi Sankyo
Dainippon Sumitomo Pharma
Outline of Major Chapters:
Chapter 1: Introduces the definition of Pharmerging, market overview.
Chapter 2: Global Pharmerging market size in revenue.
Chapter 3: Detailed analysis of Pharmerging company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Pharmerging in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
